Independent · Evidence-led · We don't sell peptides
EU / NordicsUpdated weeklyEN

Blog

Daily evidence-led peptide research, regulatory news, expert digest and explainers. Every claim sourced; no AI tells.

Page 71

Explainer

Syringes for subcutaneous peptide injection

Syringe volume, needle gauge, and length each affect subcutaneous delivery. Here is what GLP-1 prescribing information and CDC injection safety guidance say.

8 Jul 2026 · PeptideMethods Editorial Team · 5 min read
Explainer

Is tesamorelin banned in sport? WADA status

Tesamorelin is a GHRH analogue prohibited under WADA S2 in and out of competition. Here is what that means and why the TUE picture is unusual.

8 Jul 2026 · PeptideMethods Editorial Team · 5 min read
Explainer

What is tesamorelin?

Tesamorelin (Egrifta) is FDA-approved for HIV lipodystrophy. Plain-English guide to its mechanism, one approved indication, and what the Phase 3 trials found.

8 Jul 2026 · PeptideMethods Editorial Team · 4 min read
Explainer

Tirzepatide dosing: what the trials used

A trial-by-trial map of the dose escalation schedules used across the SURPASS and SURMOUNT programmes, with what each schedule produced at the primary endpoint.

8 Jul 2026 · PeptideMethods Editorial Team · 4 min read
Explainer

Tirzepatide history: discovery to approval

Six milestones trace how tirzepatide went from a laboratory dual-agonist hypothesis in 2018 to one of the most-studied prescription medicines in the world.

8 Jul 2026 · PeptideMethods Editorial Team · 4 min read
Explainer

SURMOUNT-OSA post-hoc: who benefits most

SURMOUNT-OSA post-hoc (Sleep, 2026): more-symptomatic patients saw larger subjective gains; objective AHI and weight changes were consistent across subgroups.

8 Jul 2026 · PeptideMethods Editorial Team · 4 min read
Country deep-dive

What BPC-157 costs in Denmark

BPC-157 has no marketing authorisation in Denmark: no official price, no pharmacy route, no reimbursement. What the grey-market reality looks like.

7 Jul 2026 · PeptideMethods Editorial Team · 6 min read
Country deep-dive

BPC-157 Denmark: import rules explained

BPC-157 is unauthorised in Denmark. The 2026 personal import rules explicitly restrict doping substances. What the DKMA says and what customs flags.

7 Jul 2026 · PeptideMethods Editorial Team · 7 min read
Explainer

Tesamorelin: from discovery to FDA approval

How tesamorelin moved from a lab compound to FDA approval in 2010, and why the European application was withdrawn in 2012.

7 Jul 2026 · PeptideMethods Editorial Team · 5 min read
Explainer

How Tesamorelin works: the mechanism

Tesamorelin binds GHRH receptors in the pituitary, triggers GH pulses, and raises IGF-1. Plain-English guide to the mechanism.

7 Jul 2026 · PeptideMethods Editorial Team · 4 min read
Explainer

Tesamorelin side effects and safety data

The FDA label and phase-3 trials list injection site reactions, arthralgia, edema, and a threefold rise in new-onset dysglycemia. Here is what the data show.

7 Jul 2026 · PeptideMethods Editorial Team · 4 min read
Country deep-dive

What tirzepatide costs in Germany

Cash prices, GKV reimbursement rules, PKV coverage, and the AMNOG process that determines what Mounjaro costs in Germany in 2026.

7 Jul 2026 · PeptideMethods Editorial Team · 7 min read